Literature DB >> 19296111

[Amyloidoses in the Berlin Museum of Medical History of the Charité].

C Röcken1, N Widulin, T Schnalke.   

Abstract

The Berliner Medizinhistorische Museum (Berlin Museum of Medical History) of the Charité is located in its own separate building and was officially opened in 1899. It currently houses 10,000 specimens, of which 23 were labelled with the diagnosis "amyloid" or "amyloidosis". In this retrospective study we aimed to histologically verify the diagnosis, classify the amyloid deposits immunohistochemically and correlate the type of amyloid with clinico-pathological data. The specimens were obtained between 1866 and 1987 and included 17 kidneys, five spleens and one liver. The diagnosis could be confirmed histologically using Congo red staining and polarization microscopy in 22 specimens. However, the diagnosis could not be confirmed in the oldest specimen, which had been labelled by Rudolf Virchow himself. Immunohistochemically amyloid was classified as either AA amyloidosis (19 cases) or AL amyloidosis (two cases). Tuberculosis was the most common cause of AA amyloidosis. This study shows that a surgical pathological re-evaluation of historical specimens can verify the original diagnosis. This is historically fascinating and also offers a valuable addition to student teaching.

Entities:  

Mesh:

Year:  2009        PMID: 19296111     DOI: 10.1007/s00292-009-1135-2

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  24 in total

1.  "Congo" red: out of Africa?

Authors:  D P Steensma
Journal:  Arch Pathol Lab Med       Date:  2001-02       Impact factor: 5.534

2.  A novel single-nucleotide polymorphism at the 5'-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis.

Authors:  M Moriguchi; C Terai; H Kaneko; Y Koseki; H Kajiyama; M Uesato; S Inada; N Kamatani
Journal:  Arthritis Rheum       Date:  2001-06

3.  Amyloid. Extraction and preliminary characterization of some proteins.

Authors:  E P BENDITT; D LAGUNOFF; N ERIKSEN; O A ISERI
Journal:  Arch Pathol       Date:  1962-10

Review 4.  Optical properties of amyloid stained by Congo red: history and mechanisms.

Authors:  Alexander J Howie; Douglas B Brewer
Journal:  Micron       Date:  2008-10-15       Impact factor: 2.251

5.  [Without sense and understanding? Rudolf Virchow's strategy of collecting by the example of his pathological museum].

Authors:  Thomas Schnalke
Journal:  Acta Hist Leopoldina       Date:  2007

6.  SAA1 alpha/alpha alleles in amyloidosis.

Authors:  Engin Kelkitli; Birsen Bilgici; Bülent Tokgöz; Melda Dilek; Abdülkerim Bedir; Ilkser Akpolat; Cengiz Utas; Tekin Akpolat
Journal:  J Nephrol       Date:  2006 Mar-Apr       Impact factor: 3.902

7.  Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis.

Authors:  M Moriguchi; C Terai; Y Koseki; M Uesato; A Nakajima; S Inada; M Nishinarita; S Uchida; A Nakajima; S Y Kim; C L Chen; N Kamatani
Journal:  Hum Genet       Date:  1999-10       Impact factor: 4.132

8.  X-ray diffraction studies on amyloid filaments.

Authors:  E D Eanes; G G Glenner
Journal:  J Histochem Cytochem       Date:  1968-11       Impact factor: 2.479

9.  SAA1 gene polymorphisms and the risk of AA amyloidosis in Japanese patients with rheumatoid arthritis.

Authors:  Junya Ajiro; Ichiei Narita; Fuminori Sato; Daisuke Saga; Hisashi Hasegawa; Takeshi Kuroda; Masaaki Nakano; Fumitake Gejyo
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

10.  Anti-lambda-light chain-peptide antibodies are suitable for the immunohistochemical classification of AL amyloid.

Authors:  H Kuçi; M P Ebert; C Röcken
Journal:  Histol Histopathol       Date:  2007-04       Impact factor: 2.303

View more
  1 in total

1.  Molecular and Immunohistochemical Characterization of Historical Long-Term Preserved Fixed Tissues from Different Human Organs.

Authors:  Maja Hühns; Paula Röpenack; Andreas Erbersdobler
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.